ClinicalTrials.gg
Sign In

Drug

Conestat alfa clinical trials

A product of Complement C1 Inhibitor Protein; its studies count on that page too.

studies test it
13
open now
1
in phase 3
3
first study started
2004

Keep track of what changes. Save the conestat alfa studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Ruconest
6
Conestat alfa
3
rhC1INH
2

Combined with it in one product

Recombinant Human C1 Inhibitor
4
Ruconest
4
"rhC1INH"
3
conestat alfa
3
rhC1INH
1

Studies by the year they started

13 studies that test it; most in 2020 (2)

Studies that test conestat alfa, by start year
YearStudies
20041
20051
20091
20121
20141
20171
20181
20191
20202
20211
20221
20241

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
9
Phase 3
3
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it.

Angioedemas, Hereditary
6
COVID-19
2
Ischemic Stroke
1
Acute Kidney Injury
1
Angioedema
1
Renal Insufficiency
1

Who runs them

Industry 7 · Other 6

Pharming Technologies B.V. (6) · University Hospital, Basel, Switzerland (3) · IMMUNOe Research Centers (1) · Bernstein Clinical Research Center (1) · University of Cincinnati (1) · University of Wisconsin, Madison (1)

Often tested with

Tested in the same studies.

C1 esterase inhibitor (human) (4)

Studies

Open first, then newest update. How each study uses conestat alfa is read from its arms, and is right about nine times in ten.

Testing it · 13